Electronic Cigarettes
11
1
1
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
9.1%
1 terminated out of 11 trials
88.9%
+2.3% vs benchmark
0%
0 trials in Phase 3/4
63%
5 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
Pilot Study of Communication for Dual Users of Cigarettes and E-cigarettes
Impact of Electronic Cigarette Temperature and Solvent on Biomarkers
Determination of Liquid Flavor and Nicotine Form Outcomes
Evaluating New Nicotine Standards for Cigarettes - Project 3
Effects of e-Cigarettes on Perceptions and Behavior
Effects of e-Cigarettes on Nicotine Withdrawal
The Effect of Electronic Cigarette Liquid Characteristics in Smokers.
e-Cigarette - DNA Adducts
Effects of Electronic Cigarette Settings and Liquid Concentrations in Cigarette Smokers and Electronic Cigarette Users
Effects of E-Cigarette Power and Nicotine Content in Dual Users and Vapers
Assessment of Two New Electronic Cigarettes in Cigarette Smokers